Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -31.97% is 44% above its 5-year average of -56.64%, near the high end of its 5-year range (-177.38%–-30.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.93% above its 12-month average of -33.28%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -31.97%.
RETURN ON EQUITY (ROE)
-31.97%
RETURN ON EQUITY (ROE) AVG TTM
-33.28%
RETURN ON EQUITY (ROE) AVG 3Y
-51.62%
RETURN ON EQUITY (ROE) AVG 5Y
-56.64%
RETURN ON EQUITY (ROE) AVG 10Y
-41.27%
RETURN ON EQUITY (ROE) AVG 15Y
-46.37%
RETURN ON EQUITY (ROE) AVG 20Y
-40.55%
CURRENT VS TTM AVG
+3.93%
CURRENT VS 3Y AVG
+38.06%
CURRENT VS 5Y AVG
+43.56%
CURRENT VS 10Y AVG
+22.54%
CURRENT VS 15Y AVG
+31.04%
CURRENT VS 20Y AVG
+21.16%
SECTOR MEDIAN · HEALTHCARE
-39.76%
median of 593 covered companies
CURRENT VS SECTOR MEDIAN
+19.59%
vs the sector median at left
Geron Corporation
Market Cap
$790.35M
Return on Equity (ROE)
-31.97%
TTM Avg
-33.28%
3Y Avg
-51.62%
5Y Avg
-56.64%
Market Cap
$795.58M
Return on Equity (ROE)
-16.56%
TTM Avg
0.55%
3Y Avg
-10.56%
5Y Avg
-13.37%
Market Cap
$796.03M
Return on Equity (ROE)
-13.30%
TTM Avg
11.91%
3Y Avg
154.09%
5Y Avg
54.89%
Market Cap
$787.12M
Return on Equity (ROE)
-35.02%
TTM Avg
-92.06%
3Y Avg
-115.35%
5Y Avg
-96.02%
Market Cap
$805.31M
Return on Equity (ROE)
12.32%
TTM Avg
19.75%
3Y Avg
23.44%
5Y Avg
27.16%
Market Cap
$780.99M
Return on Equity (ROE)
-40.21%
TTM Avg
-52.14%
3Y Avg
-52.14%
5Y Avg
-52.14%
Market Cap
$770.72M
Return on Equity (ROE)
-35.07%
TTM Avg
-26.66%
3Y Avg
-24.19%
5Y Avg
-5.48%
Market Cap
$770.55M
Return on Equity (ROE)
2.54%
TTM Avg
1.18%
3Y Avg
-43.07%
5Y Avg
-28.50%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $790.35M | -31.97% | -33.28% | -51.62% | -56.64% |
| AdaptHealth Corp. (AHCO)vs › | $795.58M | -16.56% | 0.55% | -10.56% | -13.37% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $796.03M | -13.30% | 11.91% | 154.09% | 54.89% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.12M | -35.02% | -92.06% | -115.35% | -96.02% |
| InMode Ltd. (INMD)vs › | $805.31M | 12.32% | 19.75% | 23.44% | 27.16% |
| Apnimed, Inc. (APMD)vs › | $807.61M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $780.99M | -40.21% | -52.14% | -52.14% | -52.14% |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | -35.07% | -26.66% | -24.19% | -5.48% |
| Mesa Laboratories, Inc. (MLAB)vs › | $770.55M | 2.54% | 1.18% | -43.07% | -28.50% |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -37.38% | -29.74% | -41.86% | -72.28% |
ROE
-32.0%
ROA
-13.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -31.97% |
| 2026-03-31 | -30.37% |
| 2025-12-31 | -37.98% |
| 2025-09-30 | -32.16% |
| 2025-06-30 | -33.91% |
| 2025-03-31 | -51.83% |
| 2024-12-31 | -62.28% |
| 2024-09-30 | -68.83% |
| 2024-06-30 | -71.59% |
| 2024-03-31 | -58.40% |
| 2023-12-31 | -74.26% |
| 2023-09-30 | -60.14% |
| 2023-06-30 | -57.31% |
| 2023-03-31 | -45.98% |
| 2022-12-31 | -177.38% |
| 2022-09-30 | -121.37% |
| 2022-06-30 | -82.32% |
| 2022-03-31 | -121.44% |
| 2021-12-31 | -91.85% |
| 2021-09-30 | -71.18% |
| 2021-06-30 | -57.23% |
| 2021-03-31 | -43.29% |
| 2020-12-31 | -35.85% |
| 2020-09-30 | -34.75% |
| 2020-06-30 | -30.49% |
| 2020-03-31 | -61.95% |
| 2019-12-31 | -50.72% |
| 2019-09-30 | -30.70% |
| 2019-06-30 | -23.68% |
| 2019-03-31 | -17.64% |
| 2018-12-31 | -15.20% |
| 2018-09-30 | -14.80% |
| 2018-06-30 | -15.95% |
| 2018-03-31 | -27.61% |
| 2017-12-31 | -26.89% |
| 2017-09-30 | -26.76% |
| 2017-06-30 | -22.69% |
| 2017-03-31 | -23.78% |
| 2016-12-31 | -24.14% |
| 2016-09-30 | -22.90% |
| 2016-06-30 | 0.95% |
| 2016-03-31 | 0.38% |
| 2015-12-31 | 0.03% |
| 2015-09-30 | -0.29% |
| 2015-06-30 | -31.40% |
| 2015-03-31 | -29.20% |
| 2014-12-31 | -27.29% |
| 2014-09-30 | -26.25% |
| 2014-06-30 | -24.01% |
| 2014-03-31 | -23.14% |
| 2013-12-31 | -64.23% |
| 2013-09-30 | -72.66% |
| 2013-06-30 | -76.98% |
| 2013-03-31 | -81.57% |
| 2012-12-31 | -80.42% |
| 2012-09-30 | -85.07% |
| 2012-06-30 | -77.44% |
| 2012-03-31 | -69.67% |
| 2011-12-31 | -66.06% |
| 2011-09-30 | -70.98% |
| 2011-06-30 | -64.47% |
| 2011-03-31 | -57.37% |
| 2010-12-31 | -57.79% |
| 2010-09-30 | -45.52% |
| 2010-06-30 | -40.95% |
| 2010-03-31 | -40.30% |
| 2009-12-31 | -40.67% |
| 2009-09-30 | -37.93% |
| 2009-06-30 | -37.64% |
| 2009-03-31 | -31.98% |
| 2008-12-31 | -36.82% |
| 2008-09-30 | -30.93% |
| 2008-06-30 | -26.63% |
| 2008-03-31 | -25.54% |
| 2007-12-31 | -17.84% |
| 2007-09-30 | -14.09% |
| 2007-06-30 | -12.16% |
| 2007-03-31 | -9.72% |
| 2006-12-31 | -18.03% |
| 2006-09-30 | -21.03% |
| 2006-06-30 | -21.17% |
| 2006-03-31 | -17.61% |
| 2005-12-31 | -17.58% |
| 2005-09-30 | -17.11% |
| 2005-06-30 | -24.68% |
| 2005-03-31 | -29.61% |
| 2004-12-31 | -65.87% |
| 2004-09-30 | -86.09% |
| 2004-06-30 | -74.04% |
| 2004-03-31 | -69.17% |
| 2003-12-31 | -28.11% |
| 2003-09-30 | -60.81% |
| 2003-06-30 | -60.69% |
